PortfoliosLab logo
BWAY vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BWAY and BSX is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

BWAY vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BrainsWay Ltd. (BWAY) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BWAY:

1.08

BSX:

1.82

Sortino Ratio

BWAY:

2.48

BSX:

2.27

Omega Ratio

BWAY:

1.28

BSX:

1.36

Calmar Ratio

BWAY:

1.69

BSX:

2.58

Martin Ratio

BWAY:

7.22

BSX:

10.49

Ulcer Index

BWAY:

12.65%

BSX:

3.82%

Daily Std Dev

BWAY:

54.11%

BSX:

22.33%

Max Drawdown

BWAY:

-88.14%

BSX:

-89.15%

Current Drawdown

BWAY:

-17.14%

BSX:

-1.31%

Fundamentals

Market Cap

BWAY:

$198.96M

BSX:

$154.62B

EPS

BWAY:

$0.22

BSX:

$1.37

PE Ratio

BWAY:

47.41

BSX:

76.28

PS Ratio

BWAY:

4.58

BSX:

8.81

PB Ratio

BWAY:

3.09

BSX:

6.96

Total Revenue (TTM)

BWAY:

$43.34M

BSX:

$17.55B

Gross Profit (TTM)

BWAY:

$32.28M

BSX:

$11.79B

EBITDA (TTM)

BWAY:

$4.90M

BSX:

$4.09B

Returns By Period

In the year-to-date period, BWAY achieves a 8.17% return, which is significantly lower than BSX's 17.85% return.


BWAY

YTD

8.17%

1M

17.65%

6M

3.34%

1Y

55.49%

3Y*

12.57%

5Y*

5.51%

10Y*

N/A

BSX

YTD

17.85%

1M

2.32%

6M

16.10%

1Y

40.35%

3Y*

36.92%

5Y*

22.61%

10Y*

19.13%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BrainsWay Ltd.

Boston Scientific Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

BWAY vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BWAY
The Risk-Adjusted Performance Rank of BWAY is 8888
Overall Rank
The Sharpe Ratio Rank of BWAY is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of BWAY is 9090
Sortino Ratio Rank
The Omega Ratio Rank of BWAY is 8686
Omega Ratio Rank
The Calmar Ratio Rank of BWAY is 9090
Calmar Ratio Rank
The Martin Ratio Rank of BWAY is 9191
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9393
Overall Rank
The Sharpe Ratio Rank of BSX is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 8989
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9191
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9595
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BWAY vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BrainsWay Ltd. (BWAY) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BWAY Sharpe Ratio is 1.08, which is lower than the BSX Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of BWAY and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

BWAY vs. BSX - Dividend Comparison

Neither BWAY nor BSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BWAY vs. BSX - Drawdown Comparison

The maximum BWAY drawdown since its inception was -88.14%, roughly equal to the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for BWAY and BSX.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

BWAY vs. BSX - Volatility Comparison

BrainsWay Ltd. (BWAY) has a higher volatility of 15.85% compared to Boston Scientific Corporation (BSX) at 4.53%. This indicates that BWAY's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

BWAY vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between BrainsWay Ltd. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20212022202320242025
11.41M
4.66B
(BWAY) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

BWAY vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between BrainsWay Ltd. and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
74.6%
68.8%
(BWAY) Gross Margin
(BSX) Gross Margin
BWAY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, BrainsWay Ltd. reported a gross profit of 8.51M and revenue of 11.41M. Therefore, the gross margin over that period was 74.6%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.

BWAY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, BrainsWay Ltd. reported an operating income of 431.00K and revenue of 11.41M, resulting in an operating margin of 3.8%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.

BWAY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, BrainsWay Ltd. reported a net income of 1.55M and revenue of 11.41M, resulting in a net margin of 13.6%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.